Vraylar was originally rejected by the FDA

Medications
1

So there’s a lot of hope for iti-007 still.

The data continue the turbulent history of cariprazine, which was originally rejected by the FDA in schizophrenia and bipolar disorder before later winning over the regulator.

3 Likes
2

I know that everyone reacts differently to these drugs but I had such an awful experience with Vraylar.
This article doesn’t surprise me to be honest.

3 Likes
3

No surprise here what the hell are the FDA thinking these days.

May aswell just use risperidone or haldol

2 Likes
4

I sure hope that ITI passes FDA approval.
I would love to be able to take pride in my appearance again, i.e. Wearing clothes that fit, and not being a slave to akithisia and motor discomfort.'it would be a dream come true

2 Likes
5

Oh and vraylar works pretty well on controlling symptoms from what I understand. So maybe there is some hope for ITI, my guess is the safety profile of vraylar wasn’t great. That stuff made me feel pretty wierd.

6

Without the stiffness I wouldn’t know what to do. Might just have to take up belly dancing or learn how to rhumba in south beach.

1 Like
7

I take Vraylar and I really like it. Only side effect is insomnia but I take Trazodone for it.